Skip to content

Joseph J Palamar

37 papers in the library · 449 citations · publishing 0-2026

Papers

Sort Most recent Most cited

Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.

Psychological Medicine October 6, 2026 Avery Chan Eun, Kevin H. Yang, Joseph J Palamar

Psilocybin use has increased in the US alongside promising therapeutic potential for depression, raising concerns that individuals may forgo conventional mental health treatment for unsupervised psilocybin use. However, no nationally representative studies have examined whether psilocybin use is associated with differential treatment utilization or perceived unmet need for mental health care...

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental and Clinical Pharmacology July 1, 2026 Nina Abukahok, Steven Lawrence, Samrachana Adhikari et al.

Ketamine is increasingly prescribed in an off-label manner to treat psychiatric disorders, raising concerns about direct-to-consumer advertising and the proliferation of clinics offering ketamine for at-home use without direct medical supervision. We aimed to identify and characterize clinics advertising ketamine for psychiatric conditions online in the New York metropolitan area (New York, New...

DOI: 10.1111/fcp.70095 (opens in new tab) Full text (opens in new tab) Ketamine Direct‐to‐consumer advertising Off‐label prescribing Telehealth

The Epidemiology of Recreational Use and Availability of DOC and DOI in the United States

Journal of Psychoactive Drugs October 9, 2025 Joseph J Palamar, Nicole D. Fitzgerald 2 citations

The U.S. Drug Enforcement Administration (DEA) proposed a rule in which they intend to place the psychedelic phenethylamines 2,5-dimethoxy-4-chloroamphetamine (DOC) and 2,5-dimethoxy-4-iodoamphetamine (DOI) into Schedule I of the Controlled Substances Act. We investigated the epidemiology of use and availability of these substances. We investigated national trends in seizures of these compounds...

DOI: 10.1080/02791072.2025.2570937 (opens in new tab) Epidemiology Recreational use Poison control Recreational drug use +7

Trends in ketamine use among nightclub attendees in New York City, 2017-2024.

International Journal of Drug Policy June 1, 2025 Joseph J Palamar 7 citations

Ketamine-related poisonings and law enforcement seizures have been increasing in the United States, but population surveys suggest that recreational use has been rare with trends being relatively stable. This study aimed to estimate trends and correlates of use among nightclub attendees-a population known for high prevalence of party drug use. Adults entering randomly selected nightclubs in New...

DOI: 10.1016/j.drugpo.2025.104825 (opens in new tab) Full text (opens in new tab) Drug trends Hallucinogens Nightclub attendees Nightlife culture +3

Tusi use among the New York City nightclub-attending population.

Addiction April 20, 2025 Joseph J Palamar, Nina Abukahok, Patricia Acosta et al. 7 citations

'Tusi', also known as 'tusibí' or 'pink cocaine', is a drug concoction which previously emerged in Latin America and Europe and has recently acquired popularity in the United States (US). Consumers are often unaware that Tusi contains a mixture of ketamine and other drugs, and the concoction can be confused with 2C/2C-B (ring-substituted phenethylamines/4-bromo-2,5-dimethoxyphenethylamine) or...

Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022.

Journal of Affective Disorders March 15, 2025 Kevin H. Yang, Wayne Kepner, Charles M Cleland et al. 19 citations

Ketamine's potential for treating depression has drawn increased clinical interest in recent years. However, despite growing therapeutic use, recreational use among individuals with depression remain underexplored. We analyzed data from the 2015-2022 National Survey on Drug Use and Health focusing on adults in the US. Trends in past-year ketamine use, overall and by depression status, were...

DOI: 10.1016/j.jad.2024.12.108 (opens in new tab) Full text (opens in new tab) Depression Nationally representative samples Ketamine-use-trends Mental-health-epidemiology +2

Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–2020

Journal of Psychoactive Drugs March 3, 2025 Wayne Kepner, Patricia Dionicio, Katie Bailey et al. 3 citations

Little is known about ecstasy/MDMA use among Asian American and Pacific Islander populations. Research is important because AAPIs face unique cultural factors that may influence use. We estimated the prevalence and correlates of lifetime ecstasy/MDMA use based on a representative sample of US AAPI adults aged ≥18 from the 2015-2020 National Survey on Drug Use and Health. An estimated 5.1% of...

Trends in poisonings involving ketamine in the United States, 2019-2023.

Drug and Alcohol Dependence March 1, 2025 Joseph J Palamar, Jennifer S. Jewell, Omar El-Shahawy et al. 9 citations

Off-label prescribing of ketamine to treat psychiatric disorders has been increasing, as has recreational use and availability of illicit ketamine. It is important to examine trends in ketamine-related poisonings to inform public health efforts. We examined data from poisonings (exposures) involving ketamine reported to Poison Centers in the US between 2019 and 2023 (n = 1519). Annual trends...

DOI: 10.1016/j.drugalcdep.2025.112549 (opens in new tab) Full text (opens in new tab) Poisonings Polydrug use Drug-safety Substance-abuse +3

Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug.

Disease-a-month : DM March 1, 2025 Andrew M Farrar, Isabelle H Nordstrom, Kaitlyn Shelley et al. 7 citations

3,4-methylenedioxymethamphetamine (MDMA; commonly referred to as "ecstasy" or "molly") is a substituted amphetamine drug that is used recreationally for its acute psychoactive effects, including euphoria and increased energy, as well as prosocial effects such as increased empathy and feelings of closeness with others. Acute adverse effects can include hyperthermia, dehydration, bruxism, and...

An Update on the Epidemiology of Tusi ("Pink Cocaine").

Current Addiction Reports 2025 Nina Abukahok, Nicole D. Fitzgerald, Joseph J Palamar

Tusi, also known as "pink cocaine," has emerged across nightlife scenes in Latin America, Europe, Australia, and the United States (US). Tusi is typically a drug mixture containing ketamine and 3,4-methylenedioxymethamphetamine (MDMA). Due to tusi's inconsistent chemical makeup, surveillance and harm reduction efforts have proven difficult for researchers and consumers alike. This review...

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.

Drug and Alcohol Dependence May 1, 2024 Joseph J Palamar, Nicole D. Fitzgerald, Thomas H Carr et al. 9 citations

Psilocybin, the principle psychoactive component in "shrooms", is regaining acceptance in therapeutic settings, leading to media coverage of medical benefits associated with use. Possession is also becoming increasingly decriminalized throughout the United States. There is a lack of data on prevalence of shroom use, but trends in law enforcement seizure data can provide one indicator of shroom...

DOI: 10.1016/j.drugalcdep.2024.111086 (opens in new tab) Full text (opens in new tab) Drug laws Drug seizures Psilocybin mushrooms Law enforcement surveillance +2

Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017-2022.

Drug and Alcohol Review May 1, 2024 Nicole D. Fitzgerald, Joseph J Palamar 5 citations

Ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) is a drug commonly used by people who attend electronic dance music (EDM) events at nightclubs and dance festivals. Drug checking has gained popularity in recent years to test for adulterants, but epidemiology studies are needed to estimate potential shifts in prevalence of drug checking to further inform harm reduction efforts. Adults entering...

Tusi: a new ketamine concoction complicating the drug landscape.

The American Journal of Drug and Alcohol Abuse September 3, 2023 Joseph J Palamar 29 citations

A drug concoction called tusi has emerged in Latin America and in Europe and is now beginning to acquire popularity in the United States. "Tusi" is a phonetic translation of "2C," a series of psychedelic phenethylamines. The concoction is also sometimes referred to as "pink cocaine" as it typically comes in the form of pink powder. However, despite its name, the concoction rarely contains 2C...

Adverse drug effects as a deterrent against willingness to use in the future among nightclub/festival attendees.

Drug and Alcohol Review September 1, 2023 Joseph J Palamar 5 citations

It is largely unknown whether adverse effects experienced from recreational drug use affect willingness to use again. This study determined whether adverse effects from select party drugs affect reported willingness to use again in the next month among a high-risk population-people who attend electronic dance music parties at nightclubs or dance festivals. Adults (age ≥ 18) entering...

Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City

Journal of Psychoactive Drugs August 21, 2023 Caroline Rutherford, Austin Le, Joseph J Palamar et al. 2 citations

Few epidemiological studies have focused on seasonal variation in the use of common psychedelics and party drugs among nightclub and festival attendees, typically those who attend electronic dance music (EDM) events. We sought to determine whether the use of different drug types varies seasonally within this population. Across 15 seasons from summer 2017 through fall 2022, we surveyed 3,935...

Characteristics of poisonings involving ketamine in the United States, 2019-2021.

Journal of Psychopharmacology August 2023 Joseph J Palamar, Nicole D. Fitzgerald, David J Grundy et al.

The use of ketamine, a controlled dissociative anesthetic, has become more widespread in recent years with recreational/nonmedical use increasing and ketamine becoming more widely available in clinics to treat depression. We examined recent trends in adverse effects related to ketamine use. US National Poison Control data were examined, focusing on ketamine exposures among those aged ⩾13...

Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.

International Journal of Drug Policy May 1, 2023 Joseph J Palamar, Austin Le, Charles M Cleland et al. 41 citations

Drug use is prevalent among people who attend electronic dance music (EDM) parties at nightclubs or festivals. This population can serve as a sentinel population to monitor trends in use of party drugs and new psychoactive substances (NPS) that may diffuse through larger segments of the population. We surveyed adults entering randomly selected EDM parties at nightclubs and dance festivals in...

Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.

Addictive Behaviors September 1, 2022 Kevin H. Yang, Benjamin H Han, Joseph J Palamar 30 citations

There is renewed interest in the clinical application of hallucinogenic substances to treat a range of psychiatric conditions. However, there is mixed evidence regarding how use of such substances outside of medical settings relates to psychological distress, depression, and suicidality. We examined data from a US representative sample of noninstitutionalized adults from the 2015-2020 National...

A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes.

Harm Reduction Journal February 5, 2022 Joseph J Palamar, İbrahim Sönmez

Dance festivals have been shown to be high-risk events for use of drugs such as ecstasy/MDMA and possible adverse effects associated with use. However, few studies have examined what makes festivals such risky environments. We aimed to determine festival-specific risk factors for adverse outcomes related to drug use. In-depth interviews were conducted with 35 key informants in North America who...

DOI: 10.1186/s12954-022-00598-5 (opens in new tab) Full text (opens in new tab) Ecstasy Dance festivals Environmental risk factors Nightlife

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines

Human Psychopharmacology: Clinical and Experimental 2020 Patricia Acosta, Joseph J Palamar 44 citations

Abstract Objective The number of novel psychedelic phenethylamines and tryptamines has continued to increase, but little academic research has focused on the effects of these substances. We sought to determine and compare the subjective effects of various substances. Methods We conducted in‐depth interviews with 39 adults (75.4% male and 87.2% White) who reported experience using psychedelic...

Diffusion of Ecstasy in the Electronic Dance Music Scene.

Substance Use & Misuse 2020 Joseph J Palamar

Ecstasy (MDMA, Molly) is among the most prevalent drugs used by people who attend electronic dance music (EDM) events; however, little recent research has examined diffusion of ecstasy in this high-risk population. Methods: 1,020 EDM event-attending adults (aged 18-40) were surveyed in NYC in 2018 using time-spacing sampling. Participants were asked about past-year ecstasy use, and those...

Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Drug and Alcohol Review January 2019 Joseph J Palamar, Monica J Barratt

Ecstasy users in the electronic dance music scene are at high risk for using ecstasy adulterated with new psychoactive substances and/or methamphetamine. We examined self-reported testing of ecstasy among users in this scene. We surveyed individuals (aged 18-40 years) entering electronic dance music parties in New York City in 2017. Past-year ecstasy users (n = 351) were asked if they had...

Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs

Drug and Alcohol Review October 9, 2018 F. Fernández-Calderón, C. Díaz-Batanero, Monica J Barratt et al.

Introduction and Aims: Polysubstance users are a high-risk population for negative health-related consequences. Although some studies have described harm reduction strategies adopted by polysubstance users, studies have not examined their effectiveness in minimising health-related consequences. We aimed to identify dosing-related harm reduction strategies in a sample of polysubstance-using...

Trends in DMT and other tryptamine use among young adults in the United States

American Journal on Addictions September 27, 2018 Joseph J Palamar, Austin Le 35 citations

Background and Objectives The popularity of tryptamines such as N,N ‐dimethyltryptamine (DMT) appears to be increasing in the United States (US), but epidemiologic literature on prevalence of use is scant. This paper aims to determine trends in prevalence and correlates of past‐year tryptamine use among a nationally representative sample of young adults in the US. Methods Participants in the...